Search results for: Adrian Towse
Filter search results
Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
4 January 2016
…direction of future research in this area. The study, written by OHE’s Sarah Karlsberg Schaffer, Patricia Cubi-Molla, Nancy Devlin and Adrian Towse, and commissioned by the Association of the British…
Additional Elements of Value for Health Technology Assessment Decisions
1 May 2017
…its potential policy impact. These are summarised in the Briefing. A two page summary of the briefing, written by Dr Chris Henshall and Professor Adrian Towse is available here. …
Establishing a Reasonable Price for an Orphan Drug
1 July 2018
…high prices in many countries. The question then arises as to what should be a reasonable price for an orphan drug? The research by OHE authors Mikel Berdud and Adrian…
OHE at ISPOR 2023
7 May 2023, 7:00am
…Session Location Lotte Steuten 07/05/2023 13:00-17:00 EDT / 18:00-22.00 BST Core Concepts and Approaches to Early-Stage Health Technology Assessment Short Course Room 109A, Level 1 Adrian Towse 07/05/2023 13:00-17:00 EDT…
Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
30 November 2022
Share this: Download publication Adrian Towse Lotte Steuten An increasingly common strategy for treating many cancers is to utilise several medicines with distinct but complementary mechanisms of action in combination…
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
…and Towse, A. (2018). R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C. OHE Research Paper 18/06, London: Office of Health Economics. | RePEc …
Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA
28 February 2019
…Cures. OHE Seminar Briefing 25. RePEc. Jönsson, B., Hampson, G., Michaels, J., Towse, A., von der Schulenburg, J.-M.G. and Wong, O., 2018. Advanced therapy medicinal products and health technology assessment…
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…be downloaded from the ICER website here. Cole, A., Towse, A., Segel C.S., Henshall, C., Pearson, S.D., 2019. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…N. and Towse, A., 2016. Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. OHE Consulting Report. RePEc. Barnsley, P., Towse, A., Karlsberg Schaffer, S. and Sussex, J.,…